Alveolus Bio secures strategic investment from Shilpa Medicare to advance into pulmonary therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, AL, has received a strategic financing round led by the Raichuru-based

To access the full article, please log in or subscribe.